JP2017518982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518982A5 JP2017518982A5 JP2016567865A JP2016567865A JP2017518982A5 JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5 JP 2016567865 A JP2016567865 A JP 2016567865A JP 2016567865 A JP2016567865 A JP 2016567865A JP 2017518982 A5 JP2017518982 A5 JP 2017518982A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- epiamb
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994450P | 2014-05-16 | 2014-05-16 | |
| US61/994,450 | 2014-05-16 | ||
| US201462045907P | 2014-09-04 | 2014-09-04 | |
| US62/045,907 | 2014-09-04 | ||
| PCT/US2015/030965 WO2015175875A1 (en) | 2014-05-16 | 2015-05-15 | Amphotericin b derivative with reduced toxicity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017518982A JP2017518982A (ja) | 2017-07-13 |
| JP2017518982A5 true JP2017518982A5 (https=) | 2018-06-28 |
| JP6543272B2 JP6543272B2 (ja) | 2019-07-10 |
Family
ID=54480735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567865A Active JP6543272B2 (ja) | 2014-05-16 | 2015-05-15 | 低減された毒性を有するアンホテリシンｂ誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9738677B2 (https=) |
| EP (1) | EP3142672B1 (https=) |
| JP (1) | JP6543272B2 (https=) |
| CA (1) | CA2981288C (https=) |
| DK (1) | DK3142672T3 (https=) |
| ES (1) | ES2749927T3 (https=) |
| WO (1) | WO2015175875A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016061437A1 (en) | 2014-10-17 | 2016-04-21 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin b |
| JP7240811B2 (ja) | 2015-04-15 | 2023-03-16 | スファンガ セラピューティクス インコーポレイテッド | アムホテリシンｂの誘導体 |
| CA3111565A1 (en) | 2018-09-07 | 2020-03-12 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| KR20220058547A (ko) * | 2019-08-08 | 2022-05-09 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 감소된 독성을 갖는 하이브리드 암포테리신 b 유도체 |
| EP4009985A4 (en) * | 2019-08-08 | 2023-09-06 | The Board Of Trustees Of The University Of Illinois | HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B |
| US20220370486A1 (en) * | 2019-08-09 | 2022-11-24 | The Board Of Trustees Of The University Of Illinois | Combination treatment of systemic fungal infections |
| AU2021325676A1 (en) * | 2020-08-10 | 2023-03-30 | The Board Of Trustees Of The University Of Illinois | Hybrid amide derivatives of amphotericin B |
| WO2024010968A2 (en) * | 2022-07-08 | 2024-01-11 | The Board Of Trustees Of The University Of Illinois | Transfer of c2'-epimerized sugars to the amphotericin b aglycone |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006528704A (ja) * | 2003-05-27 | 2006-12-21 | セラヴァンス インコーポレーテッド | グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用 |
| JP2008503586A (ja) * | 2004-06-21 | 2008-02-07 | ネクター セラピューティクス | アンフォテリシンｂを含む組成物、方法、およびシステム |
| US8513204B2 (en) * | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
| WO2014059436A1 (en) * | 2012-10-12 | 2014-04-17 | The Board Of Trustees Of The University Of Illinois | Electronic tuning of site selectivity |
| WO2016061437A1 (en) * | 2014-10-17 | 2016-04-21 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin b |
-
2015
- 2015-05-15 ES ES15793421T patent/ES2749927T3/es active Active
- 2015-05-15 WO PCT/US2015/030965 patent/WO2015175875A1/en not_active Ceased
- 2015-05-15 JP JP2016567865A patent/JP6543272B2/ja active Active
- 2015-05-15 US US15/310,815 patent/US9738677B2/en active Active
- 2015-05-15 EP EP15793421.7A patent/EP3142672B1/en active Active
- 2015-05-15 CA CA2981288A patent/CA2981288C/en active Active
- 2015-05-15 DK DK15793421.7T patent/DK3142672T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017518982A5 (https=) | ||
| JP2014507446A5 (https=) | ||
| JP2017509667A5 (https=) | ||
| EP4331677A3 (en) | Methods of treating feline coronavirus infections | |
| JP2019516735A5 (https=) | ||
| JP2016518337A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2021191784A5 (https=) | ||
| JP2018521020A5 (https=) | ||
| JP2017105793A5 (https=) | ||
| JP2013014622A5 (https=) | ||
| WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| JP2018531941A5 (https=) | ||
| JP2012092123A5 (https=) | ||
| JP2014167010A5 (https=) | ||
| EP3731847A4 (en) | PULSED ADMINISTRATION OF INHALED NITROGEN OXIDE FOR THE TREATMENT OF PULMONIC HYPERTENSION | |
| JP2013519675A5 (https=) | ||
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| ME02910B (me) | Spojevi tetrahidropirolotiazina | |
| JP2015110588A5 (https=) | ||
| CL2018001199A1 (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
| JP2020097577A5 (https=) | ||
| JP2016532632A5 (https=) | ||
| JP2017505809A5 (https=) |